Lista de obras - Tomasz Demkow - Dominio Público Uruguay

A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen

artículo científico publicado en 2006

An incidentally diagnosed prostatic ductal adenocarcinoma

artículo científico publicado en 2013

Assessment of quality of life in patients surgically treated for penile cancer: Impact of aggressiveness in surgery.

artículo científico publicado en 2017

Assessment of selected quality of life domains in patients who have undergone conservative or radical surgical treatment for penile cancer: an observational study

artículo científico publicado en 2019

Basic issues concerning health-related quality of life

artículo científico

Basic methods for the assessment of health-related quality of life in uro-oncological patients.

artículo científico publicado en 2016

Chemotherapy-Induced Takotsubo Syndrome

artículo científico publicado en 2018

Clinical significance of androgen secretion disorders in men with a malignancy.

artículo científico publicado en 2017

Contemporary treatment of metastatic renal cell carcinoma

artículo científico publicado en 2018

Does pharmacological castration as adjuvant therapy for prostate cancer after radiotherapy affect anxiety and depression levels, cognitive functions and quality of life?

artículo científico publicado en 2011

Dynamics of hormonal disorders following unilateral orchiectomy for a testicular tumor.

artículo científico publicado en 2017

Endoscopic simple prostatectomy

artículo científico publicado en 2014

Evaluation of the role of downregulation of SNF5/INI1 core subunit of SWI/SNF complex in clear cell renal cell carcinoma development

artículo científico publicado en 2017

Hand-Foot Syndrome and Progression-Free Survival in Patients Treated with Sunitinib for Metastatic Clear Cell Renal Cell Carcinoma

scientific article published on 01 January 2019

Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland

artículo científico publicado en 2004

Intravesical bacillus Calmette-Guérin therapy for T1 superficial bladder cancer

scientific article published on 18 January 2008

Mucinous tubular and spindle cell carcinoma

scientific article published on 04 September 2012

Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial

artículo científico publicado en 2009

Primary penile cancer organ sparing treatment.

artículo científico publicado en 2016

Prognostic factors in patients undergoing lymphadenectomy for squamous cell carcinoma of the penis.

artículo científico publicado en 2013

Quality of life in penile carcinoma patients - post-total penectomy

artículo científico publicado en 2016

Radiological Response and Neutrophil-to-Lymphocyte Ratio as Predictive Factors for Progression-Free and Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib

artículo científico publicado en 2019

Radiotherapy in testicular germ cell tumours - a literature review.

artículo científico publicado en 2017

Randomised phase II study of second-line olaratumab with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer

artículo científico publicado en 2018

Randomised phase III study of intravenous vinorelbine plus hormone therapy versus hormone therapy alone in hormone-refractory prostate cancer

artículo científico publicado en 2004

Randomized phase II trial of first-line treatment with sorafenib versus interferon Alfa-2a in patients with metastatic renal cell carcinoma

artículo científico publicado en 2009

Renal function after nephron-sparing surgery for renal tumors

artículo científico publicado en 2012

SWI/SNF chromatin remodeling complex and glucose metabolism are deregulated in advanced bladder cancer

artículo científico publicado en 2020

Sorafenib dose escalation in treatment-naïve patients with metastatic renal cell carcinoma: a non-randomised, open-label, Phase 2b study

artículo científico publicado en 2016

Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.

artículo científico publicado en 2009

Sorafenib in advanced clear-cell renal-cell carcinoma

artículo científico publicado en 2007

Sperm, LH FSH, testosterone evaluation in patients with testicular cancer. Preliminary study

artículo científico publicado el 1 de junio de 1998

Systemic complications in the hormonal treatment of prostate and breast cancer

artículo científico publicado en 2017

Testicular teratomas: a growing problem?

artículo científico publicado en 2018

The correlation between the incidence of adverse events and progression-free survival in patients treated with cabozantinib for metastatic renal cell carcinoma (mRCC)

artículo científico publicado en 2019

The prospective assessment of the prostatic cancer mortality with PSA progression in the groups treated or not treated by salvage local brachytherapy

artículo científico publicado en 2018

The quality of life and hormonal disturbances in testicular cancer survivors in Cisplatin era.

artículo científico publicado en 2007

The treatment of penile carcinoma: experience in 64 cases

artículo científico publicado en 1999

Treatment of stage I seminoma: 25 years of experience

artículo científico

Trebananib (AMG 386) in Combination With Sunitinib in Patients With Metastatic Renal Cell Cancer: An Open-Label, Multicenter, Phase II Study.

artículo científico publicado en 2015

Urinary incontinence after radical prostatectomy - experience of the last 100 cases

artículo científico publicado en 2011

Venous thromboprophylaxis in urological cancer surgery

scientific article published on 25 November 2019

What is the damage? Testicular germ cell tumour survivors deficient in testosterone at risk of metabolic syndrome and a need for medical intervention

artículo científico publicado en 2020

[Sperm evaluation in testicular cancer patients before and after chemotherapy]

scientific article published on 01 October 2002

Lista de obras de Tomasz Demkow

A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen

An incidentally diagnosed prostatic ductal adenocarcinoma

Assessment of quality of life in patients surgically treated for penile cancer: Impact of aggressiveness in surgery.

Assessment of selected quality of life domains in patients who have undergone conservative or radical surgical treatment for penile cancer: an observational study

Basic issues concerning health-related quality of life

Basic methods for the assessment of health-related quality of life in uro-oncological patients.

Chemotherapy-Induced Takotsubo Syndrome

Clinical significance of androgen secretion disorders in men with a malignancy.

Contemporary treatment of metastatic renal cell carcinoma

Does pharmacological castration as adjuvant therapy for prostate cancer after radiotherapy affect anxiety and depression levels, cognitive functions and quality of life?

Dynamics of hormonal disorders following unilateral orchiectomy for a testicular tumor.

Endoscopic simple prostatectomy

Evaluation of the role of downregulation of SNF5/INI1 core subunit of SWI/SNF complex in clear cell renal cell carcinoma development

Hand-Foot Syndrome and Progression-Free Survival in Patients Treated with Sunitinib for Metastatic Clear Cell Renal Cell Carcinoma

Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland

Intravesical bacillus Calmette-Guérin therapy for T1 superficial bladder cancer

Mucinous tubular and spindle cell carcinoma

Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial

Primary penile cancer organ sparing treatment.

Prognostic factors in patients undergoing lymphadenectomy for squamous cell carcinoma of the penis.

Quality of life in penile carcinoma patients - post-total penectomy

Radiological Response and Neutrophil-to-Lymphocyte Ratio as Predictive Factors for Progression-Free and Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib

Radiotherapy in testicular germ cell tumours - a literature review.

Randomised phase II study of second-line olaratumab with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer

Randomised phase III study of intravenous vinorelbine plus hormone therapy versus hormone therapy alone in hormone-refractory prostate cancer

Randomized phase II trial of first-line treatment with sorafenib versus interferon Alfa-2a in patients with metastatic renal cell carcinoma

Renal function after nephron-sparing surgery for renal tumors

SWI/SNF chromatin remodeling complex and glucose metabolism are deregulated in advanced bladder cancer

Sorafenib dose escalation in treatment-naïve patients with metastatic renal cell carcinoma: a non-randomised, open-label, Phase 2b study

Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.

Sorafenib in advanced clear-cell renal-cell carcinoma

Sperm, LH FSH, testosterone evaluation in patients with testicular cancer. Preliminary study

Systemic complications in the hormonal treatment of prostate and breast cancer

Testicular teratomas: a growing problem?

The correlation between the incidence of adverse events and progression-free survival in patients treated with cabozantinib for metastatic renal cell carcinoma (mRCC)

The prospective assessment of the prostatic cancer mortality with PSA progression in the groups treated or not treated by salvage local brachytherapy

The quality of life and hormonal disturbances in testicular cancer survivors in Cisplatin era.

The treatment of penile carcinoma: experience in 64 cases

Treatment of stage I seminoma: 25 years of experience

Trebananib (AMG 386) in Combination With Sunitinib in Patients With Metastatic Renal Cell Cancer: An Open-Label, Multicenter, Phase II Study.

Urinary incontinence after radical prostatectomy - experience of the last 100 cases

Venous thromboprophylaxis in urological cancer surgery

What is the damage? Testicular germ cell tumour survivors deficient in testosterone at risk of metabolic syndrome and a need for medical intervention

[Sperm evaluation in testicular cancer patients before and after chemotherapy]